Trim EMR 25-30% via phased execution: 15% now at $147, additional 10-15% at $150-153 resistance; hold residual with $141.50 stop
Trim EMR exposure 25-30% total via phased execution: 15% at current $147 levels plus additional 10-15% add-on trim order at the $150-153 resistance cluster. Maintain hard stop at $141.50 on residual position (just below 200 SMA at $142.47). Hold core long-term position through Q4 FY26 print. Re-engagement requires either $138-142 entry zone or confirmed close above $153 with MACD histogram turning positive. Key risks: FOMC binary event, FY26 EPS consensus migration, 200 SMA structural defense, Polymarket recession probability threshold at 20%.
| Position | Action |
|---|---|
| Current levels ($147) | Trim 15% of position |
| $150-153 resistance cluster (10 EMA/50 SMA/VWAP convergence) | Trim additional 10-15% of position |
| Weekly close below $141.50 | Full exit on residual position |
| Consensus FY26 EPS below $6.50 | Downgrade to Sell |
| Polymarket recession probability climbs above 20% | Downgrade to Sell |
EMR is a buy-the-dip opportunity where the technical pullback within an intact secular uptrend has reset the forward valuation to 20.3x (below historical average and peer quality) while structural demand tailwinds from automation, AI data-center power, and energy transition are accelerating, supported by a bulletproof balance sheet and Dividend Aristocrat capital return floor.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 150.38 | bearish |
| 50 SMA | 150.12 | bearish |
| 200 SMA | 142.47 | bullish |
| RSI(14) | 41.60 | bearish |
| MACD Line | -1.20 | bearish |
| MACD Signal | -0.24 | bearish |
| MACD Histogram | -0.97 | bearish |
| Bollinger Upper Band | 160.83 | neutral |
| Bollinger Middle Band | 153.08 | neutral |
| Bollinger Lower Band | 145.32 | neutral |
| ATR(14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above $153 with MACD histogram turning positive
Then: Re-engage/add to position
Forward valuation is compelling relative to trailing distortion
EV: +9.4% · concedes: Beta 1.23 amplifies drawdowns (cuts both ways — also amplifies upside on relief rally); Sector multiple compression risk from ETN/VRT guide-miss; Negative tangible book value is a legitimate flag; Current ratio 0.896 reflects real working capital structure; 14% Polymarket recession probability is notable (though still a tail); MACD histogram widening to -0.97 signals continued near-term weakness possible
EMR is a falling knife with broken technical momentum, deteriorating macro conditions, rich valuations on realistic forward EPS of $6.00-$6.50, and a balance sheet loaded with $27.1B in goodwill on $20.3B equity — one recessionary impulse away from impairment charges that could crater GAAP earnings.
EV: -$4.0% (expected return from $147) · concedes: EMR is high-quality with strong brand and Dividend Aristocrat status — true in the long run; Operating cash flow of $3.1B annually demonstrates cash generation ability; Net Debt/EBITDA of 1.9x is manageable for investment-grade industrial in normal conditions; Any rally to $150-$153 should be used to trim, not initiate new longs
→ vs conservative: 200 SMA at 142.47 is a lagging indicator not a floor; EMR is trading below VWAP with accelerating bearish MACD, and slicing through 200 SMA typically runs to 122-125 (17% drawdown), making the trim-versus-hold debate simple arithmetic
→ vs conservative: Dividend Aristocrat status does not insulate equity from cyclical earnings compression; consensus EPS 7.25 vs defensible estimate 6-6.50 (10-17% haircut) applied to 20x multiple gives 120-130 price target, and income is not capital preservation
→ vs conservative: AI/automation narrative is already priced in at 163.82 peak; forward P/E of 20.3x prices substantial earnings expansion that does not offer margin of safety ahead of hostile FOMC
→ vs conservative: Structural case being intact does not protect from tactical drawdowns; refusing to trim because fundamentals are good is how portfolios watch stocks drop from 163 to 147 to 142 without action
→ vs neutral: 'Wait and see through FOMC' framing causes portfolios to bleed in cyclicals; 10-year at 2007 high and industrial beta of 1.23 means asymmetric risk is firmly to downside since market has priced a hold
→ vs neutral: Bollinger band at 145.32 is not a floor but a waystation to 200 SMA at 142; band squeeze with accelerating MACD and RSI at 41.6 typically precedes directional breakout downward
→ vs neutral: ATR compression from 5.14 to 3.88 does not mean selling pressure is exhausting; compressing volatility into macro event is coiled energy that will expand, and with four momentum signals confirming breakdown, expansion favors downside
→ vs neutral: 'Hold through binary event' approach is an unacknowledged directional bet; neutral position lacks the defined re-entry framework that aggressive trim provides
| 3.88 |
| neutral |
| VWMA | 151.30 | bearish |
| Close Price (2026-09-15) | 147.00 | bearish |
Support: 145.32 · 142.47 | Resistance: 150.12 · 150.38 · 153.08 · 160.83
Technical analysis shows EMR in a short-term downtrend following a 10.3% pullback from the August peak of $163.82 to current price of $147.00. The 200 SMA at $142.47 remains the key long-term support, while $150.12-$150.38 (10 EMA/50 SMA cluster) represents the critical overhead resistance to reclaim for a bullish reversal. The MACD bearish crossover (dated ~2026-09-02-04) and widening negative histogram (-0.97) confirm accelerating downside momentum, though ATR compression (3.88, down from 5.14) suggests a potential volatility breakout is imminent.
Market Cap
$82.0 B
Beta
1.233
52-Week High
$166.35
52-Week Low
$122.64
50-Day Moving Average
$150.29
200-Day Moving Average
$143.29
Trailing P/E
32.2x
Forward P/E
20.3x
PEG Ratio
1.71
Price/Book
4.02x
EV/EBITDA
~15.4x
Dividend Yield
1.5%
TTM Revenue
$18.64 B
Gross Profit
$9.91 B
Gross Margin
53.2%
Operating Income
$5.02 B
Operating Margin
26.9%
EBITDA
$6.06 B
EBITDA Margin
32.5%
Net Income
$2.58 B
Net Margin
13.8%
EPS (TTM)
$4.57
Forward EPS
$7.25
ROE
12.8%
ROA
6.9%
Total Assets
$42.09 B
Total Debt
$14.06 B
Net Debt
$11.57 B
Net Debt/EBITDA
~1.9x
Stockholders' Equity
$20.30 B
Current Ratio
0.90
Debt/Equity
0.69x
Goodwill & Intangibles
$27.11 B
Tangible Book Value
–$6.8 B
Free Cash Flow (TTM)
$3.71 B
FCF Yield
~4.5%
Operating Cash Flow (FY25)
$3.10 B
Dividends Paid (FY25)
$1.19 B
Buybacks (FY25)
$1.17 B
Q2 FY26 Revenue
$4.35 B
Q3 FY26 Revenue
$4.56 B
Q3 FY26 EPS
$1.28
FY25 Annual Revenue
$18.02 B
FY24 Annual Revenue
$17.49 B
FY23 Annual Revenue
$15.17 B
FY22 Annual Revenue
$13.80 B
FY24→FY25 Growth
+3.0%
FY23→FY24 Growth
+15.3%
Diluted Share Count (Q3 FY26)
561.1 M
Strengths
Concerns
Emerson Electric has transformed into a focused automation powerhouse with premium margins (53.2% gross, 26.9% operating) following the $14B+ Climate Technologies divestiture. The company generates exceptional free cash flow ($3.71B TTM) at ~140-150% conversion rates, funding 60+ years of dividend growth and aggressive buybacks while maintaining manageable leverage (Net Debt/EBITDA ~1.9x). Q3 FY26 EPS of $1.28 signals a potential earnings inflection, though the forward P/E of 20.3x versus trailing 32.2x reflects significant expected EPS expansion — requiring confirmation of industrial automation recovery at Q4 FY26 earnings.
Macro: Higher-for-longer rates confirmed (94% no-cut probability); 10-year UST yield touched 2007 high intraday on Sept 15 with steepening resuming; long-end pressure is the dominant macro signal; U.S. recession odds at 14% (+6pp weekly) represent a modest stagflation tail risk; UK recession 10%, Japan 6%; risk-off flows concentrated in crypto with broad equity indices (Dow/S&P/Nasdaq) red on Sept 15; industrials and AI-infrastructure complex (ETN, VRT, GEV) showing bifurcation.